Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency

Nature Immunology

Volumn 3, Issue 4, 2002, Pages 347-353

  Corry, David B ^a   Rishi, Kirtee ^a   Kanellis, John ^a   Kiss, Attila ^a   Song, Li zhen ^a   Xu, Jie ^a   Werb, Zena ^b   Kheradmand, Farrah ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GELATINASE A; INTERLEUKIN 3;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPHYXIA; ASTHMA; CELL TRANSPORT; CHEMOTAXIS; CLEARANCE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME DEFICIENCY; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ASTHMA; CHEMOKINES, CC; CHEMOTAXIS; CYTOKINES; DIPEPTIDES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; INTERLEUKIN-13; LUNG; MALE; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTE CHEMOATTRACTANT PROTEINS; OVALBUMIN; PNEUMONIA; PROTEASE INHIBITORS; UP-REGULATION;

EID: 0036229419     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni773     Document Type: Article

References (48)

1. Pathophysiology of asthma
2. Interleukin-4 is required for the induction of lung Th2 mucosal immunity
3. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
4. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
5. Requirements for allergen- induced airway hyperreactivity in T and B cell-deficient mice
6. H2-like bronchoalveolar T-lymphocyte population in atopic asthma
7. Mediators of asthma: A new series
8. IL-4 directs the development of Th2-like helper effectors
9. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
10. IL-4 is required to generate and sustain in vivo IgE responses
11. Structure of IL-13 receptor: Analysis of subunit composition in cancer and immune cells
12. Cloning of the human IL-13Rα chain and reconstitution with the IL4Rα of a functional IL-4/IL-13 receptor complex
13. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor
14. Requirement for IL-13 independently of IL-4 in experimental asthma
15. IL-13 in allergy: Home at last
16. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma
17. Increased matrix metalloproteinase-9 in the airway after allergen challenge
18. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema
19. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma
20. Functional polymorphism in the gelatinase B gene and asthma
21. MMP2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease
22. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis
23. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration
24. NIH conference. Asthma
25. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide
26. Unaltered secretion of β-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice
27. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis
28. Reflections on chemokines
29. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation
30. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma
31. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation
32. Consequences of long-term inflammation. The natural history of asthma
33. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B
34. Lung lymphocyte elimination by apoptosis in the murine response to intratracheal particulate antigen
35. Apoptosis in resolution of inflammation
36. Corpse clearance defines the meaning of cell death
37. Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent
38. IL-4-induced migration of eosinophils in allergic inflammation
39. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
40. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma
41. Respiratory arrest in near-fatal asthma
42. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
43. Migration of eosinophils through basement membrane components in vitro: Role of matrix metalloproteinase-9
44. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development
45. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation
46. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch
47. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II
48. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors